A study showed that ANGPTL8 is linked to lipid metabolism involving glucocorticoids, a cause of non-alcoholic fatty liver disease in chronic exposure, and they demonstrated that ANGPTL8 levels and expression were suppressed with glucocorticoids through glucocorticoid receptors. Here, NR3C1 is linked to metabolic dysfunction-associated steatotic liver disease.